Flor Verghote

Updated results by @FlorVerghote of the Belgian trial on Adjuvant Radiotherapy for MIBC! Awaiting the results of the trials by @PaulSargos and @VedangMurthy @ugent @uzgent @camilleberquin @CharlesPraet @Xristodouleas @BrianBaumannMD sciencedirect.com/science/articl…

⚠️ MAY = Bladder Cancer Awareness Month 🩸Blood in your urine is ALWAYS serious❗️ 🔬Follow the IG page of the Medicine Faculty of Ghent University to learn more about our Bladder Cancer Research in the next days… ⁦@uzgent⁩ ⁦@ugent_fge⁩ instagram.com/p/C6oRsNsNsCt/…

@DrLesterColl Indeed encouraging local results for patients with R+, a high risk group often excluded from adjuvant bladder trials @fontev1

#ESTRO24 @FlorVerghote adding to the emerging role of adjuvant RT for bladder cancer Intriguing that only 3/14 pts with positive surgical margins had pelvic failures #radonc

🔥 New paper 🔥 #oligometastatic #prostatecancer #HRQoL #OligoCare cohort #E2RADIatE @EORTC @ESTRO @Mat_Guc @piet_ost @MiekeVHR 🔥Take-home message🔥 #SciComm 1. #Oligometastatic PCa had good overall health prior #SBRT 2. #SBRT had no negative impact on #QoL in first 6 mo after

The protocol pre proof of the ongoing BART trial is out @ClinOncology First Multicentre bladder ca trial from India 🇮🇳 Status: 135/154 enrolled Adj RT post Sx needs a push. Its logical, safe and hopefully will prove effective. doi.org/10.1016/j.clon… Watch this space @RadOncTMC

@PaulSargos highlighting the need for postop #bladdercancer treatment for high risk patients. Radiotherapy might be a powerful tool. @fontev1 team showing that toxicity is lower than previous old series. @VedangMurthy and @PaulSargos leading new RCTs!

International consensus guidelines for adjuvant radiation therapy for #BladderCancer after radical cystectomy: update from an IBIS Workgroup. #BeyondTheAbstract with @FlorVerghote and @fontev1 @uzgent > bit.ly/3THQsbO #PracticalRadiationOncology

(1/20) #ThesisThread @ugent_fge @uzgent @crighent @DS_UGent #SciComm Hi twitter folks! In May I defended my #PhD🎓on Optimizing #rehabilitation interventions in men with #prostatecancer receiving androgen deprivation therapy Following 🧵summarizes most important findings

@fontev1 exploring the potential role of adjuvant RT in bladder cancer during @FocusMeeting! More trials are recruiting. Don’t count RT just yet. @PaulSargos @GPloussard @PignotG

🤔 Blaaskanker, zegt het jou iets? Jaarlijks krijgen ong. 2.400 Belgen de diagnose, 3 à 4 keer meer mannen dan vrouwen. Ontdek je 🩸 in je urine, consulteer dan altijd een arts 👉 een snelle diagnose is cruciaal. #WeekvandeUrologie @CharlesPraet @camilleberquin @ugent_fge

@syeepei @OncologyForum Nice discussion at @OncologyForum. Unfortunately, many questions are unaswered about oligomet in #bladdercancer. More studies are needed! The Belgian EFFORT trial is ongoing! @FlorVerghote @komop_tgkanker

🏅Updated delineation guidelines ➡️ Adjuvant radiotherapy for #Mibc 🏅 Cystectomy bed for ALL !! ⬇️⬇️⬇️ @BrianBaumannMD @fontev1 @FlorVerghote @Xristodouleas @VedangMurthy @PietDirix @CharlienBerghen ________ #bladder #france #india #Belgium #us #world sciencedirect.com/science/articl…

@NoraSundahl PET/CT needs a little bit more effort ! clinicaltrials.gov/ct2/show/NCT04…

@piet_ost @fontev1 @komop_tgkanker @VedangMurthy @PaulSargos @BrianBaumannMD @KarelDecaestec1 Happy to share the poster

@fontev1 @FlorVerghote @komop_tgkanker @VedangMurthy @PaulSargos @BrianBaumannMD @KarelDecaestec1 Sharing the poster would be nice

Nice presentation of @FlorVerghote at #BLADDR21 in the best poster session on Adjuvant Radiotherapy after radical cystectomy for high-risk MIBC! Thanks to the support of @komop_tgkanker @VedangMurthy @PaulSargos @BrianBaumannMD @KarelDecaestec1

Kick-off of EFFORT-MIBC trial! Today first patient recruited! #bladdercancer @KarelDecaestec1 @FlorVerghote @LindsayPoppe in collaboration with @uzgent @ugent_fge @PietDirix @MaartenAlbersen. Thanks to @komop_tgkanker